Dokumente im Korb
Helmholtz Zentrum München
|
Imprint
PuSH - Publication Server of Helmholtz Zentrum München
Navigation
Home
Deutsch
Research
Advanced Search
Browse by ...
... Journal
... Publication Type
... Research Data
... Publication Year
Publication overview
Support & Contact
Contact persons
Help
Data protection
Bertlich, M.* ; Kashani, F.* ; Weiss, B.G.* ; Wiebringhaus, R.* ; Ihler, F.* ; Freytag, S.* ;
Gires, O.
; Kühnel, T.* ; Haubner, F.*
Safety and efficacy of blue light laser treatment in hereditary hemorrhagic telangiectasia.
Lasers Surg. Med.
53
, 309-315 (2021)
Publ. Version/Full Text
Research data
DOI
PMC
Open Access Gold (Paid Option)
as soon as is submitted to ZB.
Abstract
Metrics
Extra information
Background and Objectives: Hereditary hemorrhagic telangiectasia (HHT) is a hereditary condition that is associated with arteriovenous malformations. A common site for these malformations is the nasal mucosa, which is associated with severe epistaxis and debilitation for affected patients. We evaluated the efficacy and safety of blue light laser technology in treating these endonasal manifestations in a retrospective chart analysis. Additionally, we compared blue light laser technology to bipolar coagulation in an animal model. Study Design/Materials and Methods: We performed a retrospective chart analysis of all patients that were diagnosed with HHT and received endonasal blue light laser treatment between 10/2017 and 04/2019. In addition, we performed bipolar or blue light laser coagulation of all macroscopically visible vessels on thyroid gland lobes (n = 4) from Dunkin–Hartley Guinea Pigs. Hematoxylin-eosin (HE) staining was then used to visualize depth and area of coagulation surrounding these vessels. Results: One hundred and fifty-one treatments in 23 patients were analyzed. Under regular blue light laser treatment, quality of life (QOL), indicated on a visual analog scale from 1 to 10, gradually increased significantly from 5.6 ± 0.5 (before the first treatment) to 7.5 ± 0.9 (after the second treatment). Following this, QOL remained steady throughout additional treatments. Adverse effects were not recorded. HE staining showed that coagulation depth (162 ± 56 vs. 586 ± 192 µm) and area (74 ± 35 vs. 1015 ± 449 µm2) were significantly lower after laser treatment. Conclusion: Blue light laser therapy is safe and efficient in treating HHT. Damage to the surrounding tissue is significantly lower compared with bipolar coagulation. © 2020 The Authors. Lasers in Surgery and Medicine published by Wiley Periodicals LLC.
Altmetric
Additional Metrics?
[➜Log in]
Tags
Annotations
Special Publikation
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Corresponding Author
Keywords
Blue Light Laser ; Hemorrhagic Hereditary Teleangiectasis ; Hht ; Laser ; Osler
Keywords plus
ISSN (print) / ISBN
0196-8092
e-ISSN
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Journal
Lasers in Surgery and Medicine
Quellenangaben
Volume: 53,
Issue: 3,
Pages: 309-315
Article Number: ,
Supplement: ,
Series
Publisher
Wiley
Publishing Place
New York, NY
University
University place
Faculty
Publication date
0000-00-00
Application number
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Translational Metabolic Oncology (IDC-TMO)
Grants